Tenon Medical (TNON) Non Operating Investment Income (2021 - 2026)
Tenon Medical's (TNON) quarterly Non Operating Investment Income came in at $25000.0 in Q1 2026, down 59.02% year-on-year from $61000.0 in Q1 2025, and down 26.47% quarter-over-quarter from $34000.0 in Q4 2025.
Tenon Medical (TNON) Non Operating Investment Income (2021 - 2026) Analysis & Trends
Tenon Medical's Non Operating Investment Income history runs 6 years deep, the most recent figure standing at $25000.0 for Q1 2026.
- On a quarterly basis, Non Operating Investment Income fell 59.02% year-over-year to $25000.0 in Q1 2026; TTM through Mar 2026 was $200000.0, a 7.83% decrease from a year earlier, with the FY2025 full-year figure at $236000.0, up 28.96% from the prior year.
- Non Operating Investment Income declined to $25000.0 in Q1 2026 per TNON's latest filing, from $34000.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $88000.0 in Q2 2025 and bottomed at -$27000.0 in Q2 2022.
- The 5-year median for Non Operating Investment Income is $39000.0 (2024), against an average of $42882.4.
- Across the five-year window, Non Operating Investment Income soared 7100.0% in 2022 and slumped 66.67% in 2023, its largest moves.
- Year by year, Non Operating Investment Income stood at $72000.0 in 2022, then sank by 66.67% to $24000.0 in 2023, then surged by 258.33% to $86000.0 in 2024, then tumbled by 60.47% to $34000.0 in 2025, then slipped by 26.47% to $25000.0 in 2026.
- Per Business Quant, the three latest TNON Non Operating Investment Income figures stand at $25000.0 (Q1 2026), $34000.0 (Q4 2025), and $53000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Tenon Medical | 2,058.66 | -4.60 Mn | 945,000.00 | 25,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25,000.00 |
| Mar 31, 2026 | 25,000.00 |
| Dec 31, 2025 | 34,000.00 |
| Dec 31, 2025 | 34,000.00 |
| Sep 30, 2025 | 53,000.00 |
| Sep 30, 2025 | 53,000.00 |
| Jun 30, 2025 | 88,000.00 |
| Jun 30, 2025 | 88,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Dec 31, 2024 | 86,000.00 |
| Dec 31, 2024 | 86,000.00 |
| Sep 30, 2024 | 31,000.00 |
| Sep 30, 2024 | 31,000.00 |
| Jun 30, 2024 | 39,000.00 |
| Jun 30, 2024 | 39,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Dec 31, 2023 | 24,000.00 |
| Dec 31, 2023 | 24,000.00 |